FDA Authorizes Quest Diagnostics’ Proprietary Monkeypox Test for Emergency Use

First lab-developed test specifically designed to detect Monkeypox virus DNA to receive emergency use authorization during the monkeypox public health emergency SECAUCUS, N.J., Sept. 7, 2022 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic…